DIL
ACIU icon

Deeter Investments LLP’s AC Immune ACIU Stock Holding History

Deeter Investments LLP’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$314K Buy
+100,000
New +$315K 0.07% 82

Other funds holding ACIU

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Deeter Investments LLP's ACIU Position: Q4 2025 in Review

Deeter Investments LLP opened a new position in AC Immune (ACIU) in Q4 2025: 100,000 shares worth $314K. The stake represents 0.07% of the portfolio and ranks #82 among its holdings.

42 funds tracked by Wall St. Rank hold ACIU as of Q4 2025.

  • Deeter Investments LLP held 100,000 shares of AC Immune worth $314K as of Q4 2025.
  • AC Immune was a new Deeter Investments LLP position in Q4 2025.
  • AC Immune made up 0.07% of Deeter Investments LLP's portfolio in Q4 2025, its #82 holding.
  • 42 funds tracked by Wall St. Rank held AC Immune as of Q4 2025.

Based on Deeter Investments LLP's 13F filing for Q4 2025, filed 28 Aug 2026.